India, Oct. 4 -- The Maharashtra Food and Drug Administration (FDA) has cancelled the wholesale drug sale and distribution licences of Cipla Pharma & Life Sciences Ltd's carrying and forwarding (C&F) warehouse at Wadki in Pune, citing alleged regulatory and storage-related irregularities.

Assistant commissioner (drugs), circle-3 and licensing authority, FDA Pune, issued the order on October 1 in accordance with the directions of Bombay High Court, officials said on Saturday.

The administration had earlier cancelled the licences of the facility with effect from August 27 after allegedly finding irregularities involving the packaging, storage and recall of Reactin Plus Tablets. The proceedings were subsequently withdrawn in compliance wit...